"And then secondly, on branaplam. You highlighted in the slide Phase IIb is due to start in Huntington's in the second half of the year. I wonder why not any earlier. Is there COVID-related delays? Is there additional data preparation you need to do in the first half? And could that Phase IIb study be seen as a pivotal trial?"